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Utholdenhetstrening hos personer med koronar 
hjertesykdom 
 
Fysisk inaktivitet er en risikofaktor for koronar hjertesykdom (CHD). Friske 
personer som er fysisk aktive har både lavere dødelighet totalt og lavere 
dødelighet av CHD sammenlignet med personer som ikke er fysisk aktive. Det 
finnes mindre data på assosiasjonen mellom fysisk aktivitet og dødelighet blant 
personer med allerede etablert CHD, men det ser ut til at fysisk aktivitet er 
forbundet med redusert dødelighet også her. Det er fortsatt en del ubesvarte 
spørsmål om denne assosiasjonen blant personer med CHD, spesielt i forhold til 
hvor mye og hvor intens fysisk aktivitet som skal til for å redusere dødeligheten. 
Med data fra en stor befolkningsundersøkelse, Helseundersøkelsen i Nord-
Trøndelag (HUNT-1), undersøkte vi assosiasjonen mellom fysisk aktivitet og 
dødelighet blant 2137 menn og 1367 kvinner med CHD. Sammenlignet med 
referansekategorien (ingen aktivitet), var trening en gang i uka assosiert med 
redusert dødelighet hos begge kjønn. Personer som trente mer enn en gang i uka 
hadde ytterligere reduksjon i dødelighet, og trening med moderat eller høy 
intensitet ga større reduksjon enn trening med lav intensitet. 
 
Siden kondisjon målt som oksygenopptak er en sterk prediktor for død hos 
hjertepasienter, bør man finne effektive måter å øke kondisjonen blant CHD-
pasienter. Vi undersøkte betydningen av treningsintensitet i to kliniske forsøk. 
Femtini koronar bypass-opererte (CABG) pasienter ble tilfeldig fordelt til enten 
intervalltrening (AIT) på 90 % av maksimal hjertefrekvens, eller moderat 
kontinuerlig trening på 70 % av maksimal hjertefrekvens, fem dager i uka i fire 
uker ved et rehabiliteringssenter. Oksygenopptaket økte signifikant i begge 
grupper etter treningsperioden, men det var ingen forskjell mellom gruppene. 
Etter seks måneders hjemmetrening hadde bare AIT en fortsatt økning i 
oksygenopptak. 
 
Åttini pasienter med hjerteinfarkt (MI) ble tilfeldig fordelt til AIT på tredemølle 
ved 90 % av maksimal hjertefrekvens eller til gruppetrening gitt som standard 
behandling ved tre norske sykehus. Maksimalt oksygenopptak økte signifikant 
mer etter AIT på tredemølle enn etter gruppetrening. De som trente på 
tredemølle hadde høyere treningsintensitet enn de i gruppetrening. 
Blodårefunksjon økte signifikant i begge gruppene. Livskvalitet økte signifikant 
etter trening hos både CABG- og MI-pasientene. 
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Errata  
 
 
 
Paper II 
 
Figure 1, left column should be ”leg pain” (not ”legg”) 
 
Table III, legends: e’ and a’ should be named early/late diastolic annular velocity 
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Abbreviations 
A: late diastolic mitral flow velocity 
a’: late diastolic mitral velocity 
AIT: aerobic interval training 
CABG: coronary artery bypass grafting 
CHD: coronary heart disease 
DT: deceleration time of early diastolic mitral flow velocity (E) 
E: early diastolic mitral flow velocity 
e’: early diastolic mitral velocity 
E/A: the ratio of early diastolic to late diastolic mitral flow velocity 
EF: ejection fraction 
FMD: flow mediated dilatation 
HR: heart rate 
HUNT: Nord-Trøndelag health study 
MCT: moderate continuous training 
MET: metabolic equivalent 
MI: myocardial infarction 
NO: nitric oxide 
PCI: percutaneus coronary intervention 
VO2peak: peak oxygen uptake 
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Definitions 
Angina pectoris (AP): Chest pain due to ischemia of the heart muscle, generally due to 
obstruction or spasm of the coronary arteries. 
Confidence interval (CI): A quantity of the uncertainty in estimation. It is often 
reported as 95% CI, which is the range of values within which we can be 95% sure that 
the true value for the whole population lies. 
Coronary heart disease (CHD): Failure of coronary circulation to supply adequate 
blood to the cardiac muscle. It is most commonly caused by atherosclerosis.  
Endurance training: Activity in which the body’s large muscles move in a rhythmic 
manner for a sustained period of time. Examples include walking, running, and 
swimming. 
Lactate threshold: The exercise intensity at witch a sudden and sustained increase in 
blood lactate concentration is seen. This rise is due to a higher production than 
elimination of lactate in the muscles at intensities above the lactate threshold. 
Maximal oxygen uptake (VO2max): The body’s capacity to transport and use oxygen 
during a maximal exertion whole-body exercise, while breathing air at sea level.  
Myocardial infarction (MI): Myocardial cell death due to prolonged ischemia, which 
is the result of a perfusion imbalance between supply and demand. 
Peak oxygen uptake (VO2peak): The highest oxygen uptake achieved when all the 
criteria for VO2max can not be fulfilled. 
Physical activity: Any bodily movement produced by skeletal muscles that substantially 
increases energy expenditure. 
Relative risk: The risk of a (typically) adverse health outcome among an exposed group 
compared to an unexposed group. In physical activity, relative risk is typically the ratio 
of the risk of mortality when comparing groups of people with varying amounts of 
physical activity. 
Work economy: The mechanical efficiency, that is, the ratio of work done to energy 
expended. 
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Summary 
Physical inactivity is recognised as a risk factor for coronary heart disease (CHD). 
Healthy subjects who exercise have lower all-cause and CHD mortality compared to 
inactive. Also in subjects with already established CHD, being physically active seems 
to be associated with reduced mortality, but less data exist. Especially, the amount and 
intensity of exercise required for risk reduction in CHD patients is not yet fully resolved. 
With data from a population based prospective cohort study, the Nord-Trøndelag health 
study (HUNT-1), we investigated the association between physical activity and 
mortality in 2137 men and 1367 women with CHD. Compared to the reference category 
(no activity), one weekly exercise session was associated with reduced mortality in both 
genders. This inverse association became stronger with increasing exercise frequency and 
subjects reporting of moderate/high intensity exercise had a lower mortality risk than 
subjects reporting of low intensity exercise. 
 As peak oxygen uptake (VO2peak) strongly predicts mortality in cardiac patients, it is 
warranted to find effective ways to increase aerobic fitness in CHD patients. We 
investigated the impact of exercise intensity for improvements in VO2peak in two clinical 
trials. Fifty-nine coronary artery bypass surgery (CABG) patients were randomised to 
either aerobic interval training (AIT) at 90% of maximum heart rate, or moderate 
continuous training (MCT) at 70% of maximum heart rate, five days/week, for four weeks 
at a rehabilitation centre. VO2peak increased significantly in both groups after the training 
period, with no difference between groups. After six months of home exercise, only the 
AIT group had a further increase in VO2peak.  
 Eighty-nine myocardial infarction (MI) patients were randomised to treadmill 
AIT at 90% of maximum heart rate or to the group exercise programs provided by three 
Norwegian hospitals as usual care. VO2peak increased significantly more after treadmill 
AIT than after group exercise. Endothelial function, measured as flow-mediated 
dilatation, increased significantly in both groups. Health related quality of life increased 
significantly after exercise training in both CABG and MI patients. 
 Being physically active was associated with reduced mortality in subjects with 
CHD. For CABG patients at a rehabilitation centre for four weeks, both AIT and MCT 
gave significant increase in VO2peak, while six months later only the AIT group had a 
further increase. We found larger increase in VO2peak after treadmill AIT than after the 
group exercise training provided as usual care to MI patients by three Norwegian 
hospitals.  
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Introduction 
Cardiovascular disease is the leading cause of death in Europe accounting for 48% of all 
deaths. Just under half of the cardiovascular deaths are from coronary heart disease 
(CHD), which is the single most common cause of death in Europe [1]. It is estimated 
that 5-10% of all deaths and over 20% of CHD deaths in developed countries are caused 
by physical inactivity [2].  
 
 Physical activity, fitness and mortality 
Numerous epidemiological studies have reported decreased risk for both all-cause 
mortality and cardiovascular mortality in subjects who are physically active [3-6] or have 
high exercise capacity [7-11]. Moreover, physical activity decreases the risk of many 
diseases, among others cardiovascular disease [12, 13], type 2 diabetes mellitus [14, 15], 
some cancers [16, 17], and depression [18]. Although the prevalence of physical inactivity 
declined in USA between 1994 and 2004, still almost every fourth American reported of 
no physical activity in leisure-time [19]. In 2008, the prevalence of physical inactivity for 
a pooled sample of 51 countries (for the most developing countries), were about 15% for 
men and 20% for women [20]. In the just finished data collection for the third Nord-
Trøndelag health study (HUNT-3), 22% reported of no physical activity or less than 
once weekly activity, and 57% reported of exercising two times or more per week 
(personal communication). The most recent recommendations state that healthy adults 
should be moderately physically active 30 minutes or more five days per week, or 
vigorously active 20 minutes three times per week [21]. A recent study showed that these 
activity levels were associated with significantly longer survival compared to no 
physical activity [6]. The range of reductions in relative risks in physically active subjects 
varies somewhat between studies. In a recent review, Nocon et al [22] estimated that in 
general, physical activity reduced all-cause mortality by 33% (95% confidence interval, 
28-37%) and cardiovascular mortality by 35% (95% confidence interval, 30-40%) in 
healthy subjects.          
 Some epidemiological studies also exist on the association between physical 
activity and mortality in CHD patients [23-29]. Although one of these studies found higher 
mortality rates in asymptomatic CHD subjects who were physically active [29], the 
studies altogether indicate that physical activity reduces mortality also in subjects with 
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CHD. In these patients too, a curvilinear relationship between physical activity level and 
mortality risk has been suggested, with the greatest reductions in mortality risk in the 
lower end of the scale, with a levelling off at higher levels [27]. However, many of the 
existing studies are somewhat limited by small numbers of participants [23, 25, 26, 29, 30], 
investigating only one gender [23, 24, 26, 29-31], or having age limits [23-25, 27]. Due to the 
restricted numbers of participants, some of the studies had to dichotomize the subjects 
into active versus sedentary [23, 25]. In all of the remaining studies, exercise intensity was 
categorized according to absolute intensities [24, 26-29]. Subjects with CHD have a reduced 
exercise capacity and are often elderly, and therefore the relative intensity of certain 
activities may be higher than in younger and fitter subjects. Despite of the well 
documented association between physical activity and longevity, the exact shape of the 
dose-response curve remains unclear, both for healthy subject and also for CHD 
patients. Regarding healthy subjects, there are indications in the literature that the 
greatest reduction in mortality is seen when going from inactivity to the minimal activity 
category [4, 32, 33]. For instance, Wisløff et al [4] found a positive association between 
physical activity and survival, but the greatest increase in life length was seen between 
the ones being physically active once per week compared to no activity. Reduced 
physical capacity is shown to be a strong predictor of mortality in healthy subjects and 
subjects with CHD, as an increase in maximal oxygen uptake of 1-3.5 mL·kg-1·min-1 has 
been reported to be associated with ~15% improvements in survival [7, 34].   
 In summary, based on the current knowledge, physical activity is recommended 
as a means to increase life expectancy both for healthy and CHD subjects. However, the 
optimal amount and intensity of physical activity needed for protection against 
cardiovascular and all-cause mortality remains unclear, especially in subjects with CHD. 
In particular, there is a need to investigate whether there is an additional benefit of high 
intensity exercise in CHD subjects with regard to mortality. 
 
Maximal oxygen uptake (VO2max) 
A person’s maximal oxygen uptake (VO2max) can be defined as the highest rate at which 
oxygen can be taken up and used by the body during dynamic exercise using large 
muscle groups [35], and has been regarded as the gold standard for aerobic fitness [36]. 
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VO2max is the product of cardiac output and arteriovenous oxygen (a-vO2) difference, as 
shown by the Fick equation: 
 
VO2max = (HR x SV) x a-vO2 difference,  
 
where HR indicates heart rate and SV indicates stroke volume [37]. Any physiological 
structure or process that determines these variables would therefore potentially limit 
VO2max. Although there still exists some disagreement about what limits VO2max [38], 
most researchers agree that in healthy, non-athletic subjects performing maximal whole 
body exercise at sea level, the cardiac output is the predominant limiting factor [35, 39, 40]. 
Less fit subjects, like most CHD patients, are thought to be more restricted by peripheral 
factors [41]. Due to the often observed inability to reach a plateau of VO2 during exercise 
testing in patients with cardiovascular disease, peak oxygen uptake (VO2peak) is 
sometimes used instead of VO2max [37]. VO2peak is then the highest oxygen uptake reached 
in a maximal effort exercise test.  
How much VO2max increases after a period of exercise training, is dependent 
upon the intensity, frequency, and duration of each exercise session, as well as the 
length of the training programme, and the initial fitness level of the subject. Exercise 
intensity has been argued to be the key factor in producing improvements in VO2max 
since increasing intensity up to 100% of VO2max produces the greatest improvements 
across all frequencies, durations, programme lengths and initial fitness levels of the 
subjects [42]. 
 
Exercise intensity 
Exercise intensity can be described in terms of both relative and absolute intensity. 
Absolute intensity is the amount of external work that is being done by the subject, 
denoted for example in Watts, metabolic equivalent (METS) or walking speed. Relative 
intensity, in contrary, is the intensity of an activity expressed in relation to the capacity 
of the subject or as a subjective level of effort. Studies comparing equal volumes, and 
thus energy expenditure, of moderate and high intensity exercise training, have found 
significantly larger increases in VO2max after high (relative) intensity interval training in 
healthy subjects [43, 44] and in subjects with coronary heart disease [45], heart failure [46], 
the metabolic syndrome [47], and intermittent claudication [48]. Also, a recent review of 
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both epidemiological studies and clinical trials concluded that high intensity exercise 
appears to give greater cardioprotective benefits than moderate intensity exercise for 
healthy individuals [49]. 
High intensity interval training can be defined as repeated bouts of short to 
moderate duration exercise (i.e. 10 seconds to 5 minutes) at intensities above the lactate 
threshold. The exercise bouts are separated by brief periods of lower intensity work 
allowing partial but often not full recovery [50]. In contrast, moderate intensity exercise is 
typically performed as continuous work and is below the lactate threshold [51]. 
 
Exercise training in cardiac rehabilitation 
Cardiac rehabilitation has been defined by the World Health Organisation [52] as “the 
sum of activities required to influence favourably the underlying cause of the disease, as 
well as to ensure the patients the best possible physical, mental and social conditions so 
that they may, by their own efforts, preserve, or resume when lost, as normal a place as 
possible in the life of the community” (p 5). As physical inactivity is recognized as an 
important risk factor for progression of established CHD, exercise training is regarded as 
one of the core components in cardiac rehabilitation [53, 54]. Although no single 
randomised controlled trial has yet shown decreased mortality after cardiac 
rehabilitation, several meta-analyses show a 20-31% reduction in mortality for CHD 
patients who participate in exercise based cardiac rehabilitation [55-58].  
American and European recommendations on aerobic exercise training in 
patients with CHD state that the exercise intensity should be 50-85% of VO2max, 
corresponding to about 60-93% of maximum heart rate (HR). Further, it is 
recommended to exercise 3-5 days per week for 20-60 minutes each time, either as 
continuous or interval training with large muscle groups [53, 59, 60].  
 
Adaptations to exercise training in CHD patients 
Exercise training give rise to several physiological adaptations in CHD patients. In the 
following paragraphs some of these adaptations are presented, with focus on adaptations 
after aerobic exercise training (endurance training). The majority of the published 
studies on exercise training of CHD patients have used low or moderate exercise 
intensities [61-70], but a few studies report of exercising up to 90-95% of individual 
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maximum HR [45, 46, 71-73]. Since superior cardiovascular effects have been seen after 
aerobic interval training (AIT) compared to moderate continuous training (MCT) in 
healthy subjects and several patient groups [43-48], further studies on the effects of AIT in 
CHD patients are justified. Especially, there is a need to see if, and how, AIT can be 
used in clinical settings.  
 
Aerobic capacity
 
A person’s aerobic capacity is determined by the VO2max, the lactate threshold and work 
economy. Randomised controlled trials comparing exercise training with no training 
report 15-30% improvements of VO2max/peak in CHD patients after exercise training [61, 62, 
67, 68, 71, 74]. Also indirect indices of aerobic capacity, like exercise time or external work 
performed, has been reported to increase after exercise training compared to no training 
in CHD patients [63, 65, 66, 69]. Further, changes have been seen in lactate threshold [71, 72] 
after exercise training in CHD patients. Better work economy has been found after 
strength training in CHD patients [75], but is less studied after aerobic endurance training 
in these patients.  
 
Left ventricular function  
Since maximal HR is minimally affected by exercise training, increased stroke volume 
is the only optional explanation of increased cardiac output. Stroke volume is 
determined by left ventricular pre- and afterload, and myocardial contractility. Left 
ventricular preload is set by active and passive tissue properties, by the pressure in the 
left atrium, and HR. An adequate diastolic function is necessary to ensure a sufficient 
preload during exercise. When directly measuring left ventricular pressures in resting MI 
patients with left ventricular dysfunction, Miyashita et al [76] found that only variables of 
left ventricular diastolic function – and not systolic function – were significantly 
correlated to VO2peak. During exercise, both systolic and diastolic function variables 
were correlated to VO2peak, but diastolic variables more closely than systolic [76]. Using 
echocardiography at rest and post exercise, reduced diastolic function grade and high 
left ventricular filling pressures have been found to be independently associated with 
low exercise capacity in a population free of valvular heart disease or ischemia [77]. Also 
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Skaluba et al [78] found left ventricular filling pressures to be the strongest 
echocardiographic predictor of exercise capacity.  
Both diastolic and systolic left ventricular function have previously been found 
to improve in CHD patients after a period of exercise training [69, 79-81]. Yu et al [80] found 
no significant change in the proportion of patient with diastolic dysfunction after 
exercise training in MI or elective percutaneous coronary intervention (PCI) patients. 
However, in the control group they saw an increased proportion of the patients having 
an abnormal relaxation pattern after the intervention period. Further, when analysing 
only the MI subgroup, they found significantly increased early mitral flow velocity (E) 
as well as shortening of the deceleration time of the early diastolic mitral velocity (DT) 
after the exercise period. They saw that the changes in E correlated positively with gain 
in exercise capacity in the patients with an abnormal relaxation pattern [80]. In contrast, 
others have reported of no significant changes in diastolic parameters after 16 weeks of 
exercise training in patients with diastolic dysfunction [82]. Koizumi et al [69] found 
increased left ventricular ejection fraction (EF%) and end diastolic volume during 
exercise after three months of walking in MI patients without heart failure, compared to 
a control group. At rest they saw no changes in these indices after the training period, 
indicating an actual improvement in diastolic and systolic function only during exercise. 
Few previous studies have looked upon both diastolic and systolic function, and none 
has yet included aerobic interval training, in CABG patients.  
 
Endothelial function 
The endothelium is the inner cell layer of the arteries, and can be regarded as the largest 
endocrine organ of the human body [83]. Among others, one important function of the 
endothelium is to control the vasomotor tone in the vasculature. Additionally, it is the 
place for synthesis and release of various cytokines and growth factors, as well as the 
turnover and oxidation of the lipoproteins in the arterial wall [83]. Endothelial 
dysfunction is one of the most important visible changes in the early subclinical stage of 
atherosclerotic disease [84], and the grade of dysfunction is related to the extent and 
severity of CHD [85]. Further, impaired endothelial function has been found to be a 
strong independent risk factor for future cardiac events [86-90].  
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The vasomotor tone in the vascular bed is a result of the balance between 
relaxation and contraction in the smooth muscles. There are several factors that 
determine if the vessels should constrict or dilate, and the most important vasodilator of 
endothelial origin is considered to be nitric oxide (NO) [91, 92]. As a response to increased 
shear stress caused by increased blood flow, a healthy blood vessel dilates. This 
condition is called flow-mediated dilatation (FMD)[83] and NO is though to be 
responsible for FMD because of its known vasodilator effect [93]. FMD can be measured 
in the brachial artery by the use of high resolution ultrasound with 2D images of the 
artery in the longitudinal plane [94]. A sphygmomanometer is placed either above the 
antecubital fossa or on the forearm and inflated to a pressure well above the systolic 
pressure of the subject to stop the antegrade blood flow. After five minutes of occlusion, 
the sphygmanometer is deflated and reactive hyperemia will occur in the artery. The % 
difference between the basal diameter and the diameter after the deflation is FMD [94].  
Exercise training has been shown to increase FMD in CHD patients [46, 71, 95], and 
such improvement in endothelial function may represent an important mechanism by 
which exercise provides cardiovascular benefit. The most important factor in restoring 
normal endothelial function after exercise training is probably the ability to increase the 
endothelial bioavailability of NO. This is presumably caused by a restoration of the 
balance between NO production and NO inactivation by reactive oxygen species [96], and 
by up-regulating the enzyme endothelial nitric oxide synthase (eNOS) [97]. In subjects 
with the metabolic syndrome and in heart failure patients, AIT has given larger 
improvements in FMD than moderate continuous exercise [46, 47]. In MI patients, similar 
significant increases in FMD were seen after four weeks of aerobic training, strength 
training and strength plus aerobic training [95]. In a recent study, Munk et al [71] found 
significantly increased FMD after AIT in MI patients treated with percutaneous 
coronary intervention (PCI) with stent implantation. In their study, the control group did 
no exercise training [71]. Further studies on the effect of AIT compared to other exercise 
protocols on FMD in MI patients are therefore warranted. 
 
Heart rate recovery 
HR recovery is the decline in HR after cessation of a maximal effort exercise test. The 
difference between the HR at maximum and at one minute after ending the test is most 
often used as the HR recovery [61, 98-100]. Studies have shown that HR recovery is a 
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predictor of mortality both in healthy subjects and in patients referred for exercise 
testing [100, 101]. Autonomic dysfunction is a possible mechanism linking slow HR 
recovery to increased mortality, as the autonomic nervous system has been extensively 
implicated in the triggering of sudden cardiac death [102]. HR recovery has previously 
been found to increase after a period of exercise training in patients with acute 
myocardial infarction [61], in CABG patients [74], and in heart failure patients [103]. The 
impact of exercise intensity on changes in HR recovery in CHD patients is however not 
established. 
 
Circulating biomarkers of CHD 
Biomarkers may serve as surrogate end points to evaluate the effectiveness of a 
treatment [104]. The most useful circulating biomarker for cardiovascular risk 
stratification, therapeutic monitoring, and prognosis is not yet settled, and maybe are the 
traditional markers, like blood lipids, glycemic status, and C-reactive protein (CRP), not 
the most important. Increasing attention has been paid to plasma proteins that originate 
from adipose tissue, and especially adiponectin has emerged as a relevant and important 
biomarker of cardiovascular risk [105]. Adiponectin is a cytokine with antiatherogenic 
effects as it stimulates the production of NO [106], inhibits monocyte adhesion to 
endothelial cells [107], suppress both endothelial cell apoptosis [108] and the conversion of 
macrophages to foam cells [109]. Further, hypooadipionectinemia is associated with 
endothelial dysfunction [110] and plasma levels of adiponectin are negatively correlated 
with adiposity [111], the risk of type 2 diabetes [112], and CHD [113]. Increased serum 
adiponectin levels has been reported after exercise training [47, 114], but data are 
conflicting [115]. Of interest, there exists little information on the effect of exercise 
training on adiponectin levels in CHD patients. 
 
Quality of life 
When speaking about quality of life throughout this thesis, the focus is health related 
quality of life. Currently there exists no agreement on a single definition of health 
related quality of life, but most instruments measuring it include at least some items that 
cover domains of physical, emotional and social functioning [116]. A recent review has 
revealed a consistently positive association between level of physical activity and 
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quality of life in the general population [117]. Quality of life outcome measures have also 
been considered increasingly important in the evaluation of randomised controlled trials 
[118]. The reason for measuring quality of life, is to get a picture of the patient’s 
perception of the functional effect of an illness and its therapy [119]. Although cardiac 
rehabilitation programmes traditionally have concentrated upon physical functioning, 
several studies have reported increased quality of life after cardiac rehabilitation [63, 67, 
120-123]. Despite this, it has been concluded that there are not sufficient documentation of 
an effect of cardiac rehabilitation on quality of life above usual care [56].  
 
Safety of exercise training in cardiac patients 
Although physical activity is widely advocated in primary and secondary prevention of 
CHD, exercise can also acutely and transiently increase the risk of acute MI and sudden 
cardiac death in susceptible subjects [124, 125]. In supervised cardiac exercise programs, 
the rate of cardiac arrest, MI and fatality was estimated to be 1 per 116 906, 1 per 219 
970 and 1 per 752 365 patient-hours of exercise, respectively [126]. In spite of this, the 
benefits of exercise training surely outweigh the possible risks [126]. Moreover, even 
though vigorous exercise triggers sudden cardiac death, habitual vigorous exercise 
diminishes the risk [124]. In stable CHD patients participating in vigorous group exercise, 
it was found that adherence to an exercise intensity of < 95% of maximal HR seldom 
elicits ischemia [127]. 
 
Long-term adherence to exercise prescriptions 
One of the greatest challenges in the field of cardiac rehabilitation today is how to 
motivate the patients to continue with a healthy lifestyle after ending a formal 
rehabilitation program [128]. In contrast to the well established short-term benefits of 
cardiac rehabilitation, documentation of the sustainability of these benefits is scarce. 
There are indications of both unchanged, decreased, and increased aerobic capacity at 
follow-up testing 12-24 months after ending the formal program [129-133].  
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Objective and hypotheses 
 
 
The primary aims of the studies were to: 
 
1. Investigate the association between self-reported amount and intensity of exercise 
training and mortality in patients with coronary heart disease (CHD) using a large, 
unselected population (the Nord-Trøndelag Health Study, HUNT-1). 
 
Hypothesis: Physical activity is associated with reduced mortality in CHD subjects. 
  
 
 
2. Compare the effects of aerobic interval training (AIT) versus moderate continuous 
training (MCT) upon peak oxygen uptake (VO2peak) after coronary artery bypass grafting 
(CABG). 
 
Hypotheses: Four weeks of AIT increases VO2peak more than MCT in CABG patients. At 
follow-up six months later, there will be no difference between the groups. 
 
 
 
3. Compare the effects of the group exercise training provided as usual care by three 
Norwegian hospitals versus treadmill AIT upon VO2peak in myocardial infarction (MI) 
patients. 
 
Hypothesis: Treadmill AIT increases in VO2peak more than group exercise training in MI 
patients.  
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Materials and methodological considerations 
 
Subjects 
The subjects in this thesis were patients with coronary heart disease (CHD); both angina 
pectoris, myocardial infarction (MI), and bypass surgery (CABG) patients (Table 1). 
Inclusion and exclusion criteria are described in the papers.  
 
Table 1. Overview of the subjects included in the thesis 
              
  
 
Patient group 
 
   
Men 
 
Women 
 
Paper I Angina pectoris and/or myocardial infarction 2137 1367 
       
Paper II Coronary artery bypass    48 11 
       
Paper III Myocardial infarction   74 15 
             
 
 
Paper I 
In 1984-1986 the first part of the Nord-Trøndelag Health Survey (HUNT-1) was 
conducted. All residents in Nord Trøndealg county aged 20 years or more were invited 
to participate. Nearly 90% of 85,100 eligible persons filled in the questionnaire mailed 
to them together with the invitation letter. In addition, a second questionnaire was 
handed out at a health examination, together with a pre-stamped envelope. This 
questionnaire contained queries on several medical and lifestyle factors, including 
physical activity. A more comprehensive description of the survey can be found in 
Holmen et al [134]. In paper I we have used the subgroup of CHD patients in the HUNT 
database, based on their self-reported MI or angina pectoris at baseline of the survey (in 
1984-1986) (Table 1). The population of Nord-Trøndelag has been regarded as quite 
representative for the Norwegian population as a whole. Further, the population based 
design of HUNT is one of the strengths of this survey in comparison with other large 
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epidemiological surveys often using selected subgroups of a population (for example 
university alumni or certain occupational groups) [3, 14, 29, 135]. 
 
Paper II 
The CABG patients in paper II were recruited by a posted invitation sent out by the 
rehabilitation centre where the study took place. Out of 110 eligible patients, 69 
accepted to participate in the study, and 59 patients completed the study protocol (Table 
1). The subjects who participated in the study were somewhat younger than the ones 
excluded (61.1, SD 7.4 versus 66.7, SD 7.9 years). There was also slightly less women 
relative to men who participated than who got excluded (11/69 and 10/41, respectively).  
 
Paper III 
In paper III we included 107 MI patients from three Norwegian hospitals. With 18 drop 
outs, we analysed data on 89 patients (Table 1). The mean age of the subjects in our 
study was 57.4 (SD 9.5) years, which is lower than the mean age of subjects with MI at 
the cardiac section at the largest hospital in the study (72.2 years for women and 64.7 
years for men). Also, the portion of women relative to men in the study (13/89) was 
lower than the portion among all subjects with MI (30/100) in the region.  
 
Measurements 
In paper I, the primary outcome measure was all-cause mortality. Secondary measures 
were cardiovascular mortality and ischemic heart disease mortality. In both paper II and 
III changes in peak oxygen uptake (VO2peak) were the primary outcome measure. 
However, besides an increased VO2peak, there are several other physiological adaptations 
to exercise training. The adaptations investigated in this thesis comprise left ventricular 
function (paper II), endothelial function (paper III), resting heart rate (HR) (paper II and 
III), HR recovery (paper II and III), work economy (paper II) and some blood markers 
of cardiovascular disease (paper II and III). We also investigated changes in quality of 
life in paper II and III. 
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Questionnaire in paper I 
The questionnaire in paper I had three questions regarding exercise, one on the 
frequency, one on the duration, and one on the intensity of exercise (Table 2).  
 
Table 2. Questions on exercise frequency, duration and intensity in the Nord-Trøndelag Health 
Study (HUNT-1) 
EXERCISE  
By exercise we mean going for walks, skiing, swimming and working out/sports.  
How often do you exercise? (on the average)  
Never  
Less than once a week  
Once a week  
2-3 times a week  
Nearly every day  
If you exercise as often as once or several times a week:  
How hard do you exercise?  
(average)  
I take it easy, I don’t get out of breath or break a sweat  
I push myself until I’m out of breath and break into a sweat  
I practically exhaust myself  
For how long do you exercise each time? (average)  
Less than 15 minutes  
16 - 30 minutes  
30 minutes - 1 hour  
 
A relative scale was used to measure the intensity of the exercise, as the subjects’ own 
feeling of intensity was recorded. The relative intensity of exercise has previously been 
shown to better distinguish risk than absolute intensity [136]. The questions regarding 
physical activity in HUNT-1 used the Norwegian word “mosjon”. This can be translated 
into exercise or physical activity, and in this thesis as well as in paper I, these terms are 
used interchangeably. As explained in the headings in the questionnaire, the exercise 
included for example to go for a walk, cross country skiing, swimming or sports. The 
subjects were asked to take the average for a week representing the whole year, and this 
was a way to overcome the seasonal variations [137]. The HUNT-1 questionnaire did not 
discriminate between physical activity in leisure and during work, or on the way to and 
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from work. The exercise questions have been validated according to tests of VO2max, and 
there was no difference by age or sex in reporting exercise intensity or in observed 
exercise intensity relative to VO2max [4].  
 
Exercise testing 
VO2peak was measured on treadmills in paper II and III. Walking or jogging on a 
treadmill provides a common form of physiologic stress in which the subjects are more 
likely to attain a slightly higher oxygen uptake and HR than during testing on a 
stationary bike. During cycling, most people experience a feeling of local fatigue in the 
thighs and therefore stop the test earlier compared to exercising on a treadmill [51]. 
Moreover, due to the higher grade of exertion on the treadmill compared to cycling, 
treadmill walking/running has a greater ability to detect coronary artery disease [136]. The 
patients were taking their usual medications at all tests as recommended by the 
American College of Sports Medicine [137].  
In both paper II and III, we used an individualized ramp protocol, adjusted to last 
8-12 minutes [138]. The subjects walked at a predefined speed and the incline of the 
treadmill was raised 1-2% every, or every second minute. For subjects who were 
capable of running the inclination was held constant and the speed was increased by 0.5 
km/h every, or every second minute. If it seemed like the test would be shorter or longer 
than the advised time, the protocol was individually adjusted. Reasons to stop were 
subjective exhaustion or standard clinical criteria [60]. Subjective perception of exertion 
was assessed immediately after termination using the Borg CR10 scale in paper II and 
the Borg 6-20 scale in study III [139]. We used the Borg scale that was in clinical use at 
the rehabilitation centre and the hospitals, and therefore we ended up with two different 
scales in paper II and III. 
 
Heart rate recovery 
HR recovery was defined as the change in HR from peak exercise to one minute after 
peak exercise with the patient standing still on the treadmill. Some researchers 
recommend to record HR recovery both at one and two minutes [140] and others look at 
the whole slope of the HR recovery curve [141]. We chose to use a simple, but still valid, 
measure of HR recovery because we were several test leaders at the centres, and 
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therefore assumed that a more advanced protocol would give more sources of error. 
Also, HR recovery at one minute has proven to be a powerful predictor of all-cause 
mortality in subjects referred for exercise testing [100, 142].  
 
Work economy 
Oxygen uptake in mL· kg-1· min-1at a sub-maximal work load is taken as a reflection of 
work economy [143]. Before the maximal exercise test in paper II, each subject was tested 
on sub-maximal, individualized speed and at zero inclination on the treadmill. The work 
rate for each subject was identical at all testing points. We chose to individualize the 
work load to be sure that it would be a truly sub-maximal load for all patients, and since 
the motive for this measurement was intra-individual comparison. 
 
Resting and maximal heart rate 
Resting HR was measured using electrocardiography during the ultrasound assessments 
(echocardiographic recordings in paper II and flow-mediated dilatation in paper III). The 
subjects rested on an examination bench for minimum 10 minutes before the recordings. 
Maximal HR was established from the exercise tests. In paper II we reported the 
maximal HR obtained in the test as the maximum. For a person to reach his individual 
maximum HR requires however several repeated intervals of maximum effort. The HR 
at the end of an exercise test is therefore not equal to an individual’s maximum HR. 
Thus, based on practical experience, we added five beats to the HR at peak exercise to 
get the maximum HR in paper III.  
 
Left ventricular function by echocardiography 
Ultrasound investigation of the heart (echocardiography) plays a central role in the 
evaluation of left ventricular diastolic and systolic function, and different techniques 
give information on blood flow velocities, myocardial velocities and deformation of the 
myocardial tissue itself. Echocardiography was used in paper II to investigate cardiac 
volumes, systolic, and diastolic function. The most commonly used methods to study 
diastolic function and left ventricular relaxation are variables derived from Doppler 
mitral blood inflow velocity; the velocities of early (E) and late (A) diastolic mitral flow, 
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the deceleration time of E (DT) and the ratio of early diastolic to late diastolic flow 
velocity (E/A). These blood flow velocities were recorded with pulsed wave Doppler-
imaging [144]. Also Tissue Doppler imaging, a relatively new echocardiographic 
technique, was used to measure the velocity of the myocardial motion. An advantage of 
Tissue Doppler imaging is that the tissue velocities are less load-dependent than 
measurements of blood velocities [145]. 
Left ventricular diastolic dysfunction was classified in four groups; impaired 
relaxation (defined as E/A < 1, or E/A 1-2 and DT > 240 ms), restrictive filling pattern 
(defined as E/A > 2 or E/A 1-2 and DT < 140 ms) and pseudonormal filling pattern 
(defined as E/A 1-2, DT 140-240 ms and E’/A’ <1). The remaining subjects were 
classified as normal [80]. 
 
Endothelial function 
Endothelial function was measured by brachial flow mediated dilatation (FMD) in paper 
III. The optimal methodology for FMD investigation is still under debate [146], and some 
of the points of disagreements are considered below. Firstly, there has been some 
discussion in the literature regarding the placement of the cuff when measuring FMD 
[147], and the most updated guidelines now recommend distal (below the elbow) 
placement of the cuff [146, 148] to reflect the NO-mediated dilatation more accurately. 
Paper III of this thesis was however planned based on the guidelines by Corretti et al 
[149], and we therefore chose a proximal placement of the cuff. The main objection 
against a proximal occlusion, is that the dilatation in response is not solely NO mediated 
[147]. However, there has been documented a close association between angiographically 
evident CHD and FMD using a proximal occlusion [85]. Further, in several studies 
demonstrating a prognostic significance of endothelial function, the cuff was placed on 
the upper arm [87, 88, 150, 151].  
In paper III, lumen diameters of arteria brachialis were measured at three 
consecutive R-waves at baseline and after cuff release, and we used the average on each 
time point as the diameter. FMD was then calculated as the percent change in diameter 
compared to baseline. Based on experience in our lab, maximal dilatation is observed 
one minute after cuff release and therefore we analysed only at that point in time. 
 The magnitude of FMD is dependent on the stimulus imposed, that is the 
magnitude of the shear stress in the vessel, and therefore some advocate a normalisation 
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of the FMD response to the shear rate [148]. We used both non-normalised values and 
values normalised for peak shear rate, and saw no difference in results between the two. 
It is also suggested to adjust to the shear rate area under the curve, but at the time of the 
recordings this normalisation method was not yet published [152]. In fact, there still is 
disagreement about whether to normalise or not, and large between-subject variations 
have been seen in the relationship between FMD and shear rate [153, 154].  
All measurements of FMD in our study were obtained in a quiet room and after 
at least 10 hours of fasting and abstinence form caffeine and alcohol. The patients were 
also asked to restrain from strenuous physical activity for at least 24 hours before the 
data collection. 
 
 
 
   A      B 
d = (4.27+4.38+4.27)mm/3 = 4.31 mm     d = (4.62+4.67+4.56)mm/3 = 4.62 mm 
 
Figure 1. Blood vessel diameter (d) at baseline (A) and after deflation of the cuff (B).  
Flow mediated dilatation (FMD) is here calculated to be: (4.62-4.31) x 100 = 7.2% 
               4.31 
 
Blood analyses 
In addition to the blood analyses provided by the rehabilitation centre or hospital 
laboratories, adiponectin was measured in paper II and III by enzyme-linked 
immunosorbent assay (ELISA, Mercodia, Uppsala, Sweden). The analysis is based on a 
technique in which two antibodies are directed against separate antigenic determinants 
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on the adiponectin molecule (sandwich-technique). This assay measures the level of 
total adiponectin in the serum or plasma. Although there are indications in the literature 
for particular importance of high molecular weight adiponectin for vascular-protective 
activity, the functional role of the different molecular forms of adiponectin remains to be 
elucidated [108, 155]. 
 
Quality of life 
There are both generic and disease specific questionnaires on quality of life. In paper II 
and III, we chose to use the MacNew Heart Disease Health-related Quality of Life 
(MacNew) Questionnaire since it was designed to evaluate how daily activities and 
physical, emotional, and social functioning are affected by CHD and its treatment. The 
MacNew consists of 27 items which fall into three domains; an emotional, a social and a 
physical domain. The minimum score (low quality of life) in each domain is one and the 
maximum score is seven. The time frame for the MacNew is the previous two weeks, 
and it takes in average maximum ten minutes to complete the questionnaire for the 
subjects [156].  
 The validity, reliability, responsiveness, and interpretability, of the MacNew have 
been established. Overall the MacNew has been found to be reliable in that it meets a 
reproducibility standard of 0.70 for group comparison which usually is the goal in 
clinical trials [157]. Also different aspects of validity of the MacNew have been confirmed 
[156], although it is difficult to establish the criterion-related validity in the absence of a 
widely accepted criterion measure (gold standard) [157]. How sensitive a test is to change 
is called responsiveness, and the MacNew is found to be responsive and sensitive to 
change in quality of life following various interventions for CHD patients [156]. Also the 
interpretability of the MacNew, or the understanding of the meaning of the instrument’s 
quantitative scores, has been found to be good. Dixon et al [158] have investigated the 
minimal important difference, which is the smallest difference in scores which subjects 
perceive as beneficial, and found this to be 0.5 in all three domains of MacNew. The 
validity and reliability of the Norwegian version of MacNew have recently been tested 
and found to be satisfactory [159].  
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Training intervention 
As exercising with high intensity gives larger increase in VO2max, we wanted to use a 
model of high intensity aerobic training in paper II and III. Previously our research 
group has used an exercise model with 4 times 4 minutes of high intensity aerobic 
interval training (AIT) and found large increases in VO2max in subjects with the 
metabolic syndrome [47], CHD [45], and heart failure [46] (Figure 2). The same protocol 
was therefore chosen. In paper II we investigated if AIT could improve VO2peak more 
than moderate continuous training (MCT) in CABG patients. The MCT chosen was 
isocaloric to the AIT [45] and therefore potential differences between the two would be 
attributed to the intensity. In comparison with the earlier studies mentioned, the 
intervention period in paper II was short; only four weeks. One aim was therefore to 
investigate if AIT could prove to be superior to MCT even after such a limited time. 
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Figure 2. Aerobic interval training (AIT) model used in paper II and III.  
HRmax = maximum heart rate. 
 
 
In paper III we wanted to investigate the effect of the exercise training offered to MI 
patients at three Norwegian hospitals as usual care. Subjects recovering from MI are 
often offered to participate in group exercise training at the hospital for a certain period. 
The short- and long-term effects of these programs have not been extensively studied. 
We wanted to compare the cardiovascular effects of the existing programs with treadmill 
AIT. Due to the earlier mentioned studies on the superiority of AIT, interval training 
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with high intensity has become more incorporated in the clinical field of cardiac 
rehabilitation in Norway, and physiotherapists try to organise their exercise training 
according to this model. However, the exact intensity of the group exercise training was 
unknown. 
 
Exercise training and ß-blockers 
Beta-adrenergic blocking agents (ß-blockers) work by blocking the effects of the 
hormone adrenaline. The patients will thereby have lower HR during exercise than 
without this medication. Almost all subjects in paper II and III were taking ß-blockers. 
We used % of maximum (ß-blocked) HR to calculated the target HR for the exercise in 
AIT in paper II and III and for MCT in paper II [160]. If the patients got their ß-blocker 
dosage changed during the studies, we calculated a new target HR based on the work 
load that they had the previous training session. In practice, we used the same speed and 
inclination and saw what HR this gave and used this new HR as the target for the 
exercise trainings to follow. 
 
Statistics 
Cox regression analysis 
In paper I we used the Cox proportional hazards model [161] to examine the association 
between physical activity and mortality in CHD subjects. This model is quite popular in 
medical research on prospective follow-up data, and is also regarded as mathematically 
robust. The proportional hazard method is a regression analysis that computes hazard 
ratios (i.e. relative risks) of the disease by comparing the risk of disease in each category 
of a predictor variable with the risk in a chosen reference category. The analysis takes 
individual time at risk into account, and study factors may be entered both as categorical 
and as continuous variables in the regression model. The Cox model gives the 
opportunity to control for variables with a potentially confounding effect on the 
investigated association. Such confounding factors are associated with the exposure and 
independently affects the risk [162]. In paper I we first performed analyses adjusting only 
for age, and then also multivariate analyses including other potentially confounding 
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variables in addition to age. There are other possible regression models to use in survival 
analysis, but due to its robustness, it is considered as “safe” to use the Cox model when 
in doubt about what is the correct model to choose [163].  
 
Linear mixed model 
Although repeated measures data traditionally have been analysed by repeated measures 
analysis of variance (ANOVA), newer mixed effects models are considered to be a 
superior alternative [164]. A linear mixed model was therefore chosen in the analysis of 
the repeated measures data in paper II. The advantages of these models are that they can 
account for several sources of random error in the data, such as individual responses and 
error of measurement. Also, these models use all available data and subjects with 
missing values do not need to be deleted, as they have to when using repeated measures 
ANOVA. If the data is missing (completely) at random, the mixed models are valid and 
fully efficient. It is often difficult to ascertain if drop-outs are random. Often, subjects 
who do not improve are more likely to drop out of a study. In paper II it was assumed a 
random drop-out, and we attempted to check for this by comparing outcome data in the 
drop-outs with data from the whole sample. Based on this, linear mixed models are 
argued to be an appropriate choice in clinical studies with a relatively long follow-up 
time [164]. 
 
Analysis of covariance 
In paper III we analysed changes in outcome variables by analysis of covariace 
(ANCOVA). ANCOVA is in fact a regression method that relates outcome scores to 
baseline scores in each of the groups, and thereby adjust each patients follow up score 
for his or her baseline score [165]. The advantage of this model above comparing change 
scores by independent t-tests is that it controls for baseline imbalance between the 
groups.  
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Summary of results and discussion 
 
Physical activity and mortality in subjects with coronary heart 
disease (paper I) 
In paper I, we found a significant decrease in both cardiovascular and all-cause mortality 
in subjects who were physically active compared to the reference group (no activity). 
Interestingly, we saw that exercising only once weekly was associated with significant 
reduction in mortality with a relative risk of 0.79 (95% confidence interval (CI) 0.65-
0.96) for men and 0.69 (95% CI 0.54-0.88) for women. However, we also saw a 
significant trend (p<0.001) for greater reductions with increasing frequency and duration 
of exercise. Exercising for 15-30 minutes, but not less than 15 minutes, each time was 
associated with lower mortality. In line with our a priori believes we saw that exercising 
with moderate/high intensity gave greater reductions in mortality than exercising with 
low intensity. The difference between low and moderate/high intensity was 
approximately 10% for all-cause mortality. The results were similar for men and 
women, and also for all-cause and cardiovascular mortality. 
        
Exercise intensity and mortality   
Also some previous epidemiological studies have found positive associations between 
physical activity and longevity in coronary heart disease (CHD) patients [23-26, 29]. Only a 
few of the earlier studies have however been able to split the subjects into more than two 
activity groups, i.e. active versus sedentary, due to restricted number of participants. 
When studying active versus sedentary, both Steffen-Batey et al [25] and Al-Khalili et al 
[23] found lower mortality in the active groups. Batty et al [29] used three categories; 
inactive, moderately active, and active, but ended up with a small statistical power due 
to few subjects in each group. They found no statistical significant risk reduction in 
active subjects; in fact, they found an elevated risk in asymptomatic men with a positive 
exercise electrocardiography at baseline who reported to be active. Some studies have 
investigated the associations of exercise intensity and mortality. In elderly CHD 
subjects, neither Janssen and Jolliffe [27] nor Wannamethee et al [24] found additional 
effects of high intensity physical activity on mortality risk. Actually, the latter of these 
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found a slightly increased mortality in elderly male CHD patients who reported to be 
vigorously active compared to the light and moderately active men. These studies are 
therefore not in line with the results of paper I, where we found larger mortality 
reductions with moderate/high intensity exercise in CHD subject. One important 
difference between the study by Wannamethee et al [24] and our, was that they used 
absolute intensity while we used relative intensity. As physiological adaptations to 
exercise are more dependent on the relative intensity in relation to the individuals own 
maximum than to the absolute intensity [166], the use of relative intensity is considered as 
a strength of our study. In subjects with CHD, low absolute levels of physical activity 
will elicit high relative intensity due to reduced physical capacity. When comparing 
subjects at different fitness levels, there is a great difference in the relative intensity of a 
common task as walking 6 km/h. For a top athlete this will be low intensity, while for 
many CHD patients it will be at or above their maximal capacity.  
The newest recommendation for physical activity in adults defines aerobic 
intensity in absolute terms, e.g., moderate intensity comprises 3.0-6.0 metabolic 
equivalents (METS) [21]. Also, 6 METS is a threshold often used in epidemiological 
studies to indicate vigorous activity. As outlined above, it can be argued that this 
threshold is arbitrary since exercising at < 6 METS for subjects with low exercise 
capacity may elicit physiological responses associated with high intensity exercise, i.e. 
large myocardial oxygen demands [126]. The current recommendation on physical 
activity in older adults is in fact more appropriate since it defines intensity in relative 
terms [167]. Given the heterogeneity of fitness level among CHD patient, 
recommendations on physical activity should be on a relative scale. Of note, relative 
intensity has proven superior to absolute intensity in predicting CHD risk [166]. 
Whether vigorous physical activity adds to the effects of moderate intensity 
activity in a public health perspective has been debated [4, 135, 168, 169]. This uncertainty is 
also reflected in the guidelines on physical activity given through the years [170, 171] [172]. 
The updated ACSM recommendation for physical activity and public health for adults 
now advice activity with moderate intensity for a minimum of 30 minutes on five days 
or vigorous intensity for a minimum of 20 minutes on three days each week [21].  
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Minimal and optimal amount of exercise for longevity 
Minimal adherence to public health guidelines [21] on physical activity requires an 
energy expenditure of about 1000 kcal/week. In some studies, both regarding healthy 
subjects [4, 169] and CHD patients [27] physical activity levels below this energy 
expenditure associate with significant reductions in mortality risk. This was also found 
in paper I. Therefore, it may be important to acknowledge all physical activity as health 
promoting for CHD patients. At the same time, we also found significantly decreased 
mortality risk with larger amounts (both duration and frequency p  0.001 for trend) of 
exercise. When recommending physical activity to the general population, or to the 
CHD subgroup, one should aim at getting as many as possible to do sufficient exercise 
for health benefits. Recommending too large dosages of activity may make some people 
find the recommendations unattainable and thereby refrain from exercising at all. Also, 
if recommending smaller dosages than today, there will be the risk of not achieving the 
health benefits. It should therefore be emphasised that doing a little exercise is good, but 
doing more is better.  
 
Physical activity and physical capacity in CHD patients 
The question whether physical activity or capacity is the most important factor for 
survival is not fully settled. Regarding cardiovascular risk factors, Sassen et al [173] found 
greater effects of physical capacity than activity, and actually no significant effect of 
total hours of physical activity or low/moderate intensity activity. Unfortunately, we do 
not have data on the subject’s level of physical fitness in our HUNT-study. Although the 
correlation between the reported physical activity level in the HUNT questionnaire and 
VO2max has been reported to be as good as in other physical activity questionnaires [174], 
there is still only a modest correlation. Therefore, we can not conclude about physical 
capacity and mortality based on the results in paper I. The risk reduction associated with 
physical activity seen in paper I was similar as in meta-analyses on the effect of exercise 
training/rehabilitation programs for CHD patients (20-30%) [55-57]. Interestingly, 44% of 
the CHD patients reported to exercise 2 times per week or more, compared to only 24% 
in the subjects without CHD in the same population [4].  
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Randomised clinical trials of aerobic interval training in CHD 
patients (paper II and III) 
As exercise capacity is a strong predictor of mortality in CHD patients [7, 34], one should 
aim at finding optimal exercise protocols for increasing peak oxygen uptake (VO2peak) in 
these patients through randomised clinical trials. In addition, there are indications that 
being fit is even more important than being physically active per se in controlling 
cardiovascular risk factors [173]. In paper II we found significantly increased VO2peak after 
both aerobic interval training (AIT) and moderate continuous training in coronary artery 
bypass surgery (CABG) patients after four weeks at a rehabilitation centre. In contrast to 
our hypothesis that AIT would increase VO2peak more than moderate continuous training 
(MCT), we found no significant difference between the two training programs after four 
weeks. At the follow-up test six months after leaving the centre, we saw however 
significantly increased VO2peak only in the AIT group. Quality of life, heart rate (HR) 
recovery, and work economy increased significantly, and resting HR decreased 
significantly, in both groups after four weeks (non-significant between-group 
difference). At the follow-up test we saw no major changes in these secondary outcome 
measures compared to discharge. We did not find significant changes in traditional 
circulating biomarkers of cardiovascular disease or in adiponectin levels. At the follow-
up test after six months, adiponectin levels had decreased significantly in both groups 
(non-significant between-group difference). We saw no significant changes in left 
ventricular function after the exercise training period. 
In paper III, MI patients referred to exercise training at three Norwegian 
hospitals had a superior effect of treadmill AIT on VO2peak compared to the usual care 
group exercise programs. In the eight minutes with the highest intensity of each session, 
the treadmill AIT patients exercised with higher intensity than the patients attending 
group exercise, even though the hospitals aimed at reaching high intensity during the 
group exercise (Figure 3). Changes in quality of life, endothelial function, HR recovery, 
resting HR, and blood markers of cardiovascular disease were similar after treadmill 
AIT and group exercise. 
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Figure 3. Heart rate curves from two patients in paper III. The left illustration (A) is a patient in 
group exercise and the right illustration (B) is a patient in treadmill aerobic interval training.  
 
Changes is VO2peak 
In paper II, we saw a trend towards greater increase in VO2peak after AIT compared to 
MCT after the four weeks at the rehabilitation centre (group*time interaction, p=0.19). 
Probably, the relatively short training intervention period was not sufficient to give 
larger effect of AIT compared to MCT. Another possible explanation for the lack of 
difference between the groups was that all patients also participated in the regular 
exercise program at the rehabilitation centre. This program consisted of a variety of 
exercise training, both with high and moderate intensity. In total the patients did a lot of 
exercise training during these four weeks. Maybe some of them, especially in the AIT 
group, experienced an overload of training and therefore did not increase VO2peak 
optimally. The further increase in VO2peak seen at the follow-up test in the AIT group 
was presumably due to more high intensity training at home. According to their training 
diaries, half of the AIT patients were doing moderate/high intensity exercise training 
more than three times per week, while only one of the MCT patients reported this. Some 
of the apparent increase in VO2peak from discharge (4 weeks) to follow-up (6 months) 
may also be due to the fact that we tested the patients shortly after the last exercise 
session at discharge. This would possibly mask some of the training effect at four weeks 
and give a VO2peak that was actually lower than if we had tested them some days later, 
allowing a super-compensation to occur.   
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 Although the intention was high intensity AIT also in the comparison group 
(usual care group exercise) in paper III, we saw larger increase in VO2peak after treadmill 
AIT compared to group exercise. The most likely explanation for the greater increase in 
VO2peak after treadmill AIT, was the higher relative exercise intensity in this group (90% 
versus 81% of HR maximum in treadmill AIT and group exercise, respectively). 
Probably it is not the average intensity of an exercise session that is most important for 
improvements in VO2peak, rather the intensity in the periods with high intensity 
(intervals).  
 The increase in VO2peak divided by the number of AIT exercise sessions was 
similar in paper II and paper III (Figure 4). The changes were also in line with two other 
studies on the effect of AIT in CHD patients [45, 175]. In the study by Rognmo et al [45], 
VO2peak increased by 0.21 mL· kg · min-1 (0.63%) per training session, and in paper II 
and III the changes were 0.20 mL· kg · min-1 (0.74%) and 0.22 mL· kg · min-1 (0.66%), 
respectively. The number of exercise sessions varied between the studies, with 28.3 AIT 
sessions in Rognmo et al [45], 16.4 in paper II, and 20.4 in paper III. After 12 weeks of 
AIT in post MI heart failure patients, Wisløff et al [46] found an average increase in 
VO2peak per exercise session of 0.16 mL· kg · min-1. In relative means, this increase was 
in fact 1.19% per session. In moderately trained healthy subjects, an absolute increase in 
VO2peak per exercise session of 0.22 mL· kg · min-1 has been reported [43]. Hence, the 
CHD patients in paper II and III had similar increase in VO2peak per exercise session as 
healthy subjects doing AIT.  
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Figure 4. Changes in VO2peak per 
exercise session, calculated as total 
change in VO2peak divided by the 
number of exercise session per 
patient. AIT = aerobic interval training 
MCT = moderate continuous training 
GrE =group exercise training. 
* indicate significant difference 
between groups in paper III (p < 0.01). 
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As we know that exercise capacity is a strong predictor of mortality in cardiac patients [7, 
34], it is tempting to conclude that the increase in VO2peak seen in paper II and III will 
have prognostic significance for these patients. However, our studies were not designed 
to test this, rather, to investigate the changes in VO2peak with different exercise training 
protocols. The potential of an increase in VO2peak to improve the prognosis in CHD 
patients remains to be demonstrated and this will require a large, multicentre trial. In the 
meanwhile we have to rely on the meta-analyses [55-57]. 
Of interest, we see that the exercise amount and intensity used in paper III, 
correspond to the exercise amount and intensity associated with the largest risk 
reduction in paper I. Exercise training 1-3 times per week with duration of more than 30 
minutes and moderate/high intensity was associated with a 40% reduction in mortality 
for men and women combined. Again, the actual effect of exercise training on mortality 
for subjects with CHD remains to be studied in randomised controlled trials. 
 
Heart rate recovery 
In paper II we found a significant increase in HR recovery after four weeks of both AIT 
and MCT (non-significant group-difference), with no significant changes between four 
weeks and six months follow-up. In the absence of a cool-down period, a cut-off value 
of  18 beats/min has been considered abnormal and predictive of death [98]. In paper II, 
13 of the patients in AIT and ten of the patients in MCT had a HR recovery below this 
value before the training period. The numbers were reduced to seven in each group after 
four weeks and to four and six at the follow-up after six months in the AIT and MCT 
groups, respectively (Figure 5). It can be argued that the increase in HR recovery seen 
was due to spontaneous recovery after the bypass surgery, however, others have found 
HR recovery to be virtually unchanged in CABG patients who did not exercise [74]. Also, 
increased HR recovery has been found in chronic angina pectoris patients after a period 
of exercise training [176].  
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Figure 5. Number of patients in paper II 
with a heart rate recovery 18 beats/min.  
BL = baseline 
4w = at discharge from the rehabilitation 
centre  
6m = six months follow-up 
AIT = aerobic interval training 
MCT = moderate continuous training
 
 
In contrast to the results in paper II, HR recovery of the MI patients in paper III did not 
increase significantly after the training period. Gialluria et al [70] found increased HR 
recovery in MI patients after 12 weeks of exercise training. The reason for this 
difference in response is presently not known. The patients included in paper III were 
quite fit MI patients with a HR recovery at baseline of 32.2 (± 9.6) beats/min, and a 
possible explanation for no change could therefore be that they already had a HR 
recovery close to normal at baseline. Only six subjects had a value  18 beats/min before 
the training period in paper III (reduced to four subjects after the training period). In 
comparison, the baseline HR recovery in Gialluria et al [70] was 17.1 (±1.8) and 18.8 (± 
2.1) beats/min in the two training groups, respectively.  
 
Circulating biomarkers of CHD 
We saw no major changes in traditional circulating biomarkers of CHD (such as total 
and high-density lipoprotein (HDL) cholesterol) in either paper II or III. This is in line 
with Kim et al [177] who reported no significant changes in total cholesterol, HDL, low-
density lipoprotein cholesterol or triglycerides after 6 months of exercise training in 
CHD patients. We did however find significant increases in adiponectin, a recently 
emerged cytokine with anti-atherosclerotic properties produced in the adipose tissue, in 
both papers [105]. In paper II, adiponectin increased between the test at the end of the 
training period at the rehabilitation centre (4w) and the follow-up test (6m) in both the 
AIT and MCT groups (non-significant between-group difference). Also in paper III, 
adiponectin increased after both group exercise and treadmill AIT (non-significant 
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between-group difference). Changes in adioponectin after exercise training have not 
been studied extensively in CHD patients. Previous studies have reported of increased 
levels of circulating adiponectin after exercise training in subjects with conditions 
related to CHD, like the metabolic syndrome [47], type 2 diabetes [178, 179] and obesity 
[114], although the data are not consistent [115].  
In both paper II and III, serum ferritin decreased significantly after exercise 
training in all groups. This was unexpected, and we have to look at these changes as 
hypothesis-generating for further studies. Increased ferritin levels have been linked to 
incidence of CHD, but the relationship is not fully understood and not consistent in all 
studies (for a review, see You et al [180]). Of interest, both adiponectin and ferritin were 
recently shown to be part of a new model for predicting development of type 2 diabetes 
[181].  
 
Quality of life 
Quality of life increased significantly in paper II and III after the exercise training 
period. In paper II, we saw that the improvement was sustained at six months follow-up. 
All domains of the MacNew Heart Disease Health-related Quality of Life Questionnaire 
(MacNew) improved in both studies, indicating that their general quality of life, not just 
the physical domain, improved. When comparing the results from paper II and III, we 
see that the changes in quality of life scores after the rehabilitation period are quite 
similar in the two. The CABG patients in paper II had a lower score in the physical and 
social domain at baseline than the MI patients in paper III. This is also reflected in their 
lower VO2peak at baseline. When considering the surgery the CABG patients had prior to 
the inclusion, this is not so surprising. The similar changes we saw after the training 
periods in both papers may indicate that exercise training has the potential to increase 
quality of life in CHD patients with various starting points. In both papers we saw 
changes in quality of life of magnitudes that have been considered to be clinically 
important in all domains [158]. The three domains of the MacNew overlap in some extent, 
since some of the questions in the questionnaire are counted in more than one domain, 
and this has to be acknowledged in the interpretation of the results. Interestingly, the 
quality of life of the CHD patients in paper II and III did not differ much from normative 
data [158]. Actually, they had average values that were equal or higher than the general 
population at baseline, and still we saw significant, clinically important increases in 
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quality of life after exercise training. Our results are in line with several previous studies 
showing improved quality of life after cardiac rehabilitation [63, 120-123]. 
 
Left ventricular function 
Apart from a decrease in early diastolic mitral flow velocity (E) after AIT, we saw no 
major changes in left ventricular function in paper II. As E has a non-linear relation to 
diastolic dysfunction due to its load dependency, early diastolic mitral velocity (e’) was 
considered to be a more robust marker of left ventricular diastolic function. Also the fact 
that none of the other variables characterising diastolic function changed after exercise 
made us interpret the change in E with caution. We therefore concluded with no 
significant changes in either diastolic or systolic function after four weeks of exercise 
training in CABG patients in paper II. Four weeks may be insufficient to engender 
alterations in cardiac function, and the contribution of cardiac function to training 
adaptation may require studies of greater duration [82, 182]. Some previous studies on left 
ventricular function in CHD patients agree with ours regarding systolic function [80, 183]. 
Amundsen et al [183] found improved early diastolic myocardial relaxation rate in CHD 
patients after eight weeks of AIT three times weekly. One could therefore assume that 
the training period needs to be longer than four weeks to get cardiac adaptations. The 
increase in VO2peak seen in paper II may therefore be due to noncardiac factors.  
Or else, it is possible that cardiac changes could be apparent using 
echocardiography during work or immediately post exercise. There are examples in the 
literature of changes in cardiac function after a period of exercise training detectable 
only when using exercise echocardiography [69, 184].  
 
Flow-mediated dilatation 
We found significantly increased flow-mediated dilatation (FMD) after both group 
exercise training and treadmill AIT in paper III. The optimal intensity, volume, and 
modality of exercise training for FMD improvements in CHD patients is not yet settled. 
Earlier studies on heart failure patients [46] and subjects with the metabolic syndrome [47] 
have reported of larger FMD improvements after AIT compared to moderate continuous 
exercise. In paper III, we compared AIT with an exercise protocol with a higher 
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intensity than the comparison groups in the mentioned studies, and this may be the 
reason for the non-significant difference between the groups.  
 
Clinical implications 
The main reason for carrying out paper I-III was to get more knowledge regarding 
exercise training in CHD patients, and thereby to give scientifically documented 
recommendations on exercise in these patients. Hopefully the clinical field of cardiac 
rehabilitation will implement some of our findings. Paper I indicated that the minimal 
effective dose of physical activity was only 15-30 minutes once weekly for significant 
reductions in mortality. Also, we found larger reductions associated with moderate/high 
intensity activity than with low intensity. Both these observations should be 
communicated to CHD patients, especially patients not attending organised 
rehabilitation. It is to be hoped that such documentation will motivate the patients to do 
at least a minimum of exercise. Although we have to be cautious in interpreting the 
results from an epidemiologic study, we could tell the patients to exercise at least once 
weekly instead of several times as we told the patients to after the intervention period of 
paper II and III. However, there will probably be larger reductions in mortality with 
more exercise. In addition, there are other positive health effects of more frequent 
exercise.  
The patients in paper II and III can be regarded as quite representative for CABG 
patients at a Norwegian rehabilitation centre and MI patients at Norwegian hospitals. As 
outlined in the methods section, the MI patients in paper III were younger than MI 
patients at the cardiac unit at the largest hospital in the study. Therefore it is uncertain 
whether the conclusions of paper III apply to the general MI patient population. 
However, others have found no major differences in the responses in exercise capacity 
to exercise training in CHD patients 45-65 compared to 66-75 years [63]. Although 
increased exercise capacity has been reported after exercise training also in very old MI 
patients (>75 years), the increase was lower than in younger patients [63].  
The patients in both paper II and III are regarded as relatively fit CHD patients, 
based on their relatively high initial VO2peak, in comparison with other studies on this 
patient group. One possible reason for this is that we used treadmills in the exercise 
testing whereas many others [61, 62, 67, 68, 71, 74, 95] used stationary bikes. 
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Feasibility of AIT 
When inspecting the training diaries from paper II, we saw that 12 out of 23 patients 
managed to keep on doing AIT as home exercise. In the MCT group, 16 out of 25 
reported to exercise > 3 times per week with moderate intensity, and only one patient 
with high intensity. In advance, we had actually hypothesised that it would be more 
feasible to do MCT at home and that these patients would adhere better to the 
prescriptions and thereby increase more in VO2peak. The results showed however that 
AIT was feasible and that the adherence was as good in this group as in MCT. In 
addition to the 12 patients in AIT reporting moderate or high intensity > 3 times per 
week, five reported to exercise > 3 times per week with moderate intensity only. Several 
of the patients randomised to AIT told us that they found it a bit hard to do AIT, but they 
experienced that they were getting more fit by doing it. Our impression was that the 
follow-up test was a motivational factor for carrying out these exercise programs. This is 
an observation that could have clinical implications as repeated exercise testing could 
motivate more CHD patients to exercise.  
Paper II and III investigated the use of treadmill AIT in clinical settings. A 
substantial part of the exercise training was lead by physiotherapists without former 
experience with treadmill AIT, but we experienced no major problems with getting the 
patients to do this kind of exercise training. The three hospitals in paper III already 
intended to do AIT organised as group exercise. Our study has however showed that it is 
not so easy to reach high intensity in group exercise as when using treadmills in CHD 
patients. Using heart rate monitors more actively and making sure that the patients are 
exercising at high intensity in periods of the exercise session could make the group 
exercise as effective as treadmill training for these patients. This remains however to be 
studied. 
 
Gender aspects 
We saw no major gender differences neither in mortality associated with physical 
activity in the epidemiologic study nor in the effects of exercise training in the clinical 
studies. However, we saw some differences in the amount and intensity of exercise 
reported by men and women in paper I. As much as one third of the women reported of 
no activity, but only 14% of the men reported not to be active. Further, half of the men 
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and 40% of the women reported to exercise two or more times per week. Also, more 
men than women reported to do exercise with moderate/high intensity, with 11% and 
3% of active men and women, respectively. These data suggest that there is a need to 
address women in particular when recommending exercise training for CHD patients.  
In paper II and III we wanted to include both men and women, but in practice we 
experienced that women were excluded more often than men due to co-morbidity giving 
physical limitations. One explanation for this could be that women in average get CHD 
at a higher age than men. Also studies included in meta-analyses are most often based on 
data on men only; actually Taylor et al [56] reported that although women were included 
in about half of the studies, they constituted only 20% of the patients. Furthermore, there 
is still published only a few epidemiological studies on the association between physical 
activity and mortality including women with CHD [23, 25]. Although women were 
included by Steffen-Batey et al [25], their analyses were done on both genders together. 
Al-Khalili et al [23] included only women below 66 years so their population was 
different from our. Generally, these and our study show the same benefit of physical 
activity for CHD women as for men, with a tendency to even greater mortality 
reductions among women compared to men in our study (tables 2-4 in paper I). 
  
Ethical considerations 
All three study protocols in this thesis were approved by the regional ethical committee.  
To study the effects of exercise training in CHD patients, it would have been interesting 
to have control groups who were advised not to do exercise in paper II and III. This was 
however considered to be unethical due to the well documented benefits of exercise for 
these patients [55-58, 61-63, 69, 71, 74]. 
 
Safety of AIT 
Currently there is little information on the safety of high intensity aerobic training in 
CHD patients. However, in our research group we have carried out several studies using 
the AIT model, and so far counted ~2800 uncomplicated exercise bouts of AIT in CHD 
patients [45, 46, 175] (+ paper II, III, and unpublished data). Also other research groups have 
carried out AIT in CHD patients without reporting serious adverse events [71, 73]. There 
clearly is a need for further investigating the safety aspect of AIT in CHD patients. 
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Limitations 
Some study limitations are acknowledged. Several of the participants in paper I have 
probably changed their level of physical activity since the baseline data collection in 
1984-1986. As mortality rate reductions are more associated with recent activity than 
past activity [185], this would probably underestimate the true difference in survival 
between the physically active and sedentary subjects [186]. In epidemiologic studies there 
will always be difficult to establish unbiased cause-effect relationships. To try to avoid 
reversed causation, we also performed the analyses with adjustment for disability status. 
We then saw only minor changes in the results, indicating that the disease severity in the 
sedentary group was not the reason for higher mortality rates. Due to the limited number 
of patients reporting to get exhausted when exercising, we had to merge the sweat and 
exhausted categories of intensity into one to get more statistical power. This weakened 
our possibility to examine the effect of high intensity exercise.  
There are some possible limitations to paper II as well. The most striking one 
being the additional exercise training performed by both groups when staying at the 
rehabilitation centre. This was recognised in advance of the study, but we though it 
would be hard to recruit patients to just walking on treadmills for four weeks when they 
were at a rehabilitation centre fully equipped for all kinds of activities. To minimize the 
bias introduced by the additional exercise training, we could have asked the patients to 
exercise according to the intensity zones prescribed in the study protocol also in the 
additional exercise session. Another limitation in this study was that we did only record 
resting echocardiography and not during or immediately post exercise. Left ventricular 
changes may have been detectable if we could have used exercise echocardiography as 
indicated by others [69, 184]. Also, the study would have been better if we had gotten more 
detailed training diaries from all subjects or had objectively measured physical activity 
in the follow-up period. 
 In paper III we experienced some difficulties in carrying out a study in three 
different hospitals. This resulted in different protocols used in measuring work 
economy, FMD and also in registering excluded subjects. Data on work economy and 
excluded subjects are therefore not reported in paper III, and FMD data are reported 
only from two of the hospitals. Also, it would be nice to have a better registration of the 
amount and intensity of the home exercise training of the subjects as they were advised 
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to exercise once weekly on their own during the study period. In paper III we report only 
results from before and after the training period, with no follow-up data, and this is 
regarded as a limitation.  
 
Conclusions  
Using data from a prospective, population-based cohort study (Nord-Trøndelag Health 
Study, HUNT-1), we found physical activity to be associated with decreased mortality in 
subjects with coronary heart disease. Exercising once weekly for 15-30 minutes was 
found to be enough to reduce both cardiovascular mortality and all-cause mortality in 
both men and women. Moderate or high exercise intensity was associated with 
approximately 10% lower mortality risk compared to low intensity.  
        Peak oxygen uptake (VO2peak), heart rate (HR) recovery and quality of life 
increased significantly after four weeks of both aerobic interval training (AIT) and 
moderate continuous exercise training (MCT) in coronary artery bypass surgery patients. 
At the follow-up testing six months later, AIT had a superior increase in VO2peak 
compared to MCT. 
        VO2peak increased significantly more after 12 weeks of AIT versus the group 
exercise training offered to myocardial infarction (MI) patients as usual care by three 
Norwegian hospitals. The exercise intensity was significantly higher in AIT compared to 
the group exercise training, indicating an importance of exercise intensity for 
improvements in VO2peak after MI. 
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Aerobic interval training versus continuous moderate
exercise after coronary artery bypass surgery: A
randomized study of cardiovascular effects
and quality of life
Trine T. Moholdt, MSc,a Brage H. Amundsen, PhD,a Lene Annette Rustad, MD,a Alexander Wahba, PhD,a,b
Kjersti T. Løvø, PT,c Lisbeth R. Gullikstad, PT,c Anja Bye, PhD,a Eirik Skogvoll, PhD,a,d
Ulrik Wisløff, PhD,a and Stig A. Slørdahl, PhDa,e Trondheim and Røros, Norway
Background Peak oxygen uptake (VO2peak) strongly predicts mortality in cardiac patients. We compared the effects of
aerobic interval training (AIT) versus moderate continuous training (MCT) on VO2peak and quality of life after coronary artery
bypass grafting (CABG).
Methods Fifty-nine CABG patients were randomized to either AIT at 90% of maximum heart rate or MCT at 70% of
maximum heart rate, 5 d/wk, for 4 weeks at a rehabilitation center. Primary outcome was VO2peak, at baseline, after
rehabilitation (4 weeks), and after 6 months of home-based exercise (6 months).
Results VO2peak increased between baseline and 4 weeks in AIT (27.1 ± 4.5 vs 30.4 ± 5.5 mL·kg−1·min−1, P < .001)
and MCT (26.2 ± 5.2 vs 28.5 ± 5.6 mL·kg−1·min−1, P < .001; group difference, not significant). Aerobic interval training
increased VO2peak between 4 weeks and 6 months (30.4 ± 5.5 vs 32.2 ± 7.0 mL·kg−1·min−1, P < .001), with no significant
change in MCT (28.5 ± 5.6 vs 29.5 ± 5.7 mL·kg−1·min−1). Quality of life improved in both groups from baseline to 4 weeks,
remaining improved at 6 months. There were no changes in echocardiographic systolic and diastolic left ventricular function.
Adiponectin increased between 4 weeks and 6 months in both groups (group differences, not significant).
Conclusions Four weeks of intense training increased VO2peak significantly after both AIT and MCT. Six months later, the
AIT group had a significantly higher VO2peak than MCT. The results indicate that AIT and MCT increase VO2peak similarly in the
short term, but with better long-term effect of AIT after CABG. (Am Heart J 2009;158:1031-7.)
Many patients are enrolled in cardiac rehabilitation
programs after coronary artery bypass grafting (CABG). A
recent meta-analysis indicated that such programs reduce
total and cardiac mortality by 20% to 26% compared to
standard medical care.1 Exercise capacity has been shown
to be the best predictor of survival, both in healthy
individuals and in subjects with cardiovascular disease.2,3
Despite exercise training having become a central element
of cardiac rehabilitation, the best way to structure the
exercise with respect to amount, mode, frequency, and
intensity is still unknown. Aerobic interval training (AIT) has
been shown to improve cardiovascular function more than
moderate continuous training (MCT) in patientswith angina
pectoris,4 metabolic syndrome,5 heart failure,6 and also in
healthy subjects.7 In these studies, the training period has
lasted 8–16 weeks. Some patients, however, are offered to
stay at residential rehabilitation centers for shorter periods,
undergoing more intense training programs.
This randomized controlled study aimed to investigate
the effect of AIT versus MCT on peak oxygen uptake
(VO2peak) in CABG patients staying at a rehabilitation
center for 4 weeks. We hypothesized that AIT would
increase VO2peak more than MCT and that there would no
longer be a difference between them after 6 months'
home exercise because of insufficient exercise training in
both groups. Secondary outcome measures were left
ventricular function, heart rate recovery (HR recovery),
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resting heart rate (HR), work economy, quality of life, and
blood markers of cardiovascular disease.
Methods
Patients
Coronary artery bypass grafting patients referred to a
residential rehabilitation center 4 to 16 weeks postoperatively
were included. Exclusion criteria were heart failure, inability to
exercise, or drug abuse.
Exercise training
The aerobic exercise training program consisted of treadmill
walking, 5 days a week for 4 weeks. Patients were randomized
to either AIT or MCT. Aerobic interval training consisted of
8 minutes warm-up, followed by 4 times of 4-minute intervals
with HR at 90% of maximum HR, with active pauses of 3 minutes
of walking at 70% of maximum HR. The exercise session was
terminated by 5 minutes cool-down. The MCT group walked
continuously at 70% of maximum HR for 46 minutes to ensure
isoenergetic training protocols.4 The intensity was controlled by
HR monitors (Polar Electro, Kempele, Finland) and the patients
also reported their perceived exertion according to the Borg
CR10 scale.8 In addition, patients participated in ordinary
training sessions at the rehabilitation center consisting of a
variety of exercise modes and intensities, of 45 to 60 minutes
duration. This additional exercise training was identical in both
groups. The exact intensity of 58 such sessions was measured by
making a subset of patients wear HR monitors.
At discharge from the rehabilitation center, all patients
received written advices to exercise at home 3 to 4 times per
week with the same intensity and duration as they were
randomized to while at the center and a training diary to register
their exercise training.
Outcomes
The primary outcome measure was VO2peak. Secondary
outcome measures were left ventricular function, HR recovery,
resting HR, work economy, quality of life, and blood markers of
cardiovascular disease. We measured these outcomes at 3 time
points: at baseline, after 4 weeks of rehabilitation at the center
(4w), and at follow-up 6 months after discharge from the center
(6m). Left ventricular function, work economy, and resting HR
were measured only at baseline and 4w.
Cardiorespiratory measurements. VO2peak was mea-
sured on treadmill. Respiratory gas was analyzed (Oxycon Delta,
Jaeger, Hochberg, Germany), and 12-lead electrocardiography
was monitored continuously (Cardiosoft GE Medical Systems,
Freiburg, Germany). Blood pressure was measured every second
minute using an automatic device (Bosotron 2, Bosch & Sohn,
Jungingen, Germany).
We used a ramp protocol individually adjusted to last 8 to 12
minutes after warm-up.9 Maximal HR at the end of the test was
set as the individuals' maximum HR. HR recovery was defined as
the change in the HR from peak exercise to 1 minute after peak
exercise with the patient standing still on the treadmill. Oxygen
uptake in milliliters per kilogram per minute at a fixed
submaximal work load defined work economy.
Echocardiography. Echocardiography was performed in 38
subjects during supine rest in the left lateral position using a
Vivid Five scanner with a 2.5-MHz phased array probe (GE
Vingmed Ultrasound, Horten, Norway). Data were stored
digitally and analyzed off-line. Mitral annular velocities in systole
(S′) and early (e′) and late (a′) diastole were measured by pulsed
tissue Doppler images in the septal, lateral, anterior, and
posterior points and averaged. Mitral flow velocity (E) was
measured by averaging 3 cycles. Ejection fraction (EF), end-
diastolic volume, and end-systolic volume were measured by the
modified Simpson biplane method. An investigator blinded for
group allocation and time of recording analyzed the data.
Blood analyses. Venous blood was drawn after 10 hours of
overnight fasting and analyzed by investigators blinded for the
subjects' group allocation. We analyzed for high-density
lipoprotein cholesterol, low-density lipoprotein cholesterol,
triglycerides, sodium, potassium, creatinine, glucose, albumin,
ferritin, and hemoglobin using standard local procedures.
Adiponectin was measured in plasma using enzyme immunoas-
say (Mercodia, Uppsala, Sweden) in 23 randomly selected
subjects from each group.
Quality of life. Quality of life variables were assessed using
the MacNew questionnaire. MacNew has been proved to be a
valid, reliable, responsive test and applicable to patients
after CABG.10
Sample size and randomization procedure
A difference in VO2peak improvement (from baseline to 4w) of
3.0 mLdkg−1dmin−1 between the 2 groups was considered
clinically important.3 Given a within-group standard deviation of
4.0, this yields a standardized difference of 0.75. With a 2-tailed t
test for independent samples at a power of 0.8 and α = .05, a
total of 58 subjects had to be enrolled.11 The actual statistical
analysis performed also takes within-person correlation into
account, thereby improving power.
Subjects were included after initial assessments, then
randomly assigned to either AIT or MCT, stratified by gender.
The randomization code was developed using a computer
random number generator, by another unit at the university to
ensure blinding.
Ethics
The Regional Committee for Medical Research Ethics
approved the study, and the study was conducted in accordance
with the Declaration of Helsinki. All subjects gave their
informed, written consent.
Statistical analysis
To model the outcome variable VO2peak over time, we used a
linear mixed effects model. This allows for observations missing
at random, as well as repeated measurements by inclusion of an
individual offset as a random effect.12 Patient age and sex were
included as covariates to improve precision. Post hoc compar-
isons of time points within groups were based on the estimated
marginal means and corresponding covariance matrix, using the
software R.13 Other analyses were performed using SPSS for
Windows (version 15.0; SPSS, Chicago, IL). To investigate
within-group comparisons at different time points of the
secondary outcomes, we did paired t tests if a normal
distribution could be assumed; otherwise, we used Wilcoxon
nonparametric signed rank test. Between-group comparisons of
echocardiography variables were done using analysis of
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covariance with the baseline values as covariates. Tests were 2-
sided and P values ≤.05 were considered significant; no
correction for multiple tests was applied.
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Results
Participant flow and protocol deviations
We recruited patients between April 2004 and Novem-
ber 2006 (Figure 1). Baseline characteristics of the 2
groups were well balanced (Table I). There were no
major complications or cardiac events during the study
period. One patient was excluded after randomization to
MCT because of a large pericardial effusion that had not
been discovered at the time of allocation. Oxygen uptake
data on one patient in the AIT group were excluded from
the analysis because of a technical error in the
measurement. This patient refused retesting. Only sub-
jects attending ≥14 exercises were included. Two
subject in AIT and 3 subjects in MCT changed their β-
blocker dosage during the rehabilitation stay, and 5
subjects in AIT and 2 in MCT changed their dosage
between 4w and 6 months.
Follow-up testing (6m) was done 27.5 (SD 3.3) and 27.0
(SD 2.7) weeks after 4 weeks in AIT and MCT,
respectively. Five patients in AIT and 6 in MCT did not
turn up for follow-up testing, for the following reasons:
work-related (n = 3), comorbidity (n = 3), refusal (n = 4),
Figure 1
Flow chart of the participants throughout the study.
Table I. Patient characteristics and medication use at baseline
AIT (n = 28) MCT (n = 31)
Age (y) 60.2 (6.9) 62.0 (7.6)
Male/female 24/4 24/7
Days since operation 62 (18) 63 (19)
Body mass index (kg/m2) 26.0 (6.2) 28.1 (3.5)
Initial VO2peak mL·kg−1·min−1) 27.1 (4.5) 26.2 (5.2)
Type 2 diabetes mellitus (no. of subjects) 4 2
Medications (no. of subjects)
β-Blockers 27 31
Statins 28 31
Diuretics 3 8
ACE inhibitors 5 7
If not otherwise stated, values are mean ± SD. ACE, Angiotensin-converting enzyme.
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and relocation (n = 1). At baseline there was no
significant difference in VO2peak between those who
turned up and those who did not (26.8 mLd kg−1dmin−1
[SD 4.9] vs 26.0 mLd kg−1dmin−1 [SD 4.9] 2-sample t test,
P = .62). Neither was there any significant difference in
quality of life.
Implementation of interventions
The AIT group attended 16.4 (range 14-19) exercise
sessions on the treadmill, and the MCT group, 16.7 (range
14-19). In addition, each subject carried out 16.5 (range 12-
19) other training sessions during the 4 weeks. The AIT
group exercised at 92% (SD4.6) of HRmaximumduring the
intervals and reported their subjective exhaustion to be at
6.1 (SD 0.9) at the Borg scale. The MCT group exercised at
74% (SD 3.5) of HR maximum, with a Borg scale of 2.9 (SD
0.9). In the other training sessions at the center, thepatients
exercisedwith high intensity in 31% andmoderate intensity
in 69% of the registered sessions, respectively.
Outcomes
Both groups showed a significant increase in VO2peak
between baseline and 4w. Between 4w and 6m, only the
AIT group increased VO2peak significantly, yielding a
group difference at 6m of 3.0 mLd kg−1dmin−1 (P = .04,
95% CI 0.2-5.7 mLd kg−1dmin−1) (Table II, Figure 2).
Women had a VO2peak about 5.0 mLd kg
−1dmin−1 less than
Table II. Cardiorespiratory variables, quality of life, and blood markers at baseline (BL), 4w, and 6m
AIT MCT
BL (n = 28) 4w (n = 28) 6m (n = 23) BL (n = 31) 4w (n = 31) 6m (n = 25)
Maximal exercise test
Vo2peak (mL · kg−1 · min−1) 27.1 ± 4.5 30.4 ± 5.5⁎ 32.2 ± 7.0†,‡ 26.2 ± 5.2 28.5 ± 5.6⁎ 29.5 ± 6.7
Perceived exertion 8.3 ± 1.5 8.2 ± 1.3 7.9 ± 1.3 8.1 ± 1.5 7.6 ± 1.9 7.1 ± 1.8
RER at Vo2peak 1.13 ± 0.07 1.14 ± 0.07 1.15 ± 0.08 1.13 ± 0.06 1.13 ± 0.08 1.15 ± 0.09
Heart rate recovery (1 min) 19.6 ± 6.8 22.5 ± 7.6§ 25.5 ± 8.6 20.3 ± 9.4 25.4 ± 8.4§ 24.6 ± 7.7
Resting heart rate (beat/min) 68.6 ± 8.4 66.4 ± 8.7§ - 68.8 ± 9.5 63.9 ± 8.8║ -
Work economy
VO2peak (mL · kg−1 · min−1) 16.0 ± 2.7 13.9 ± 2.1⁎ - 16.3 ± 3.1 13.8 ± 2.6⁎ -
Heart rate (beat/min) 106 ± 16.8 93 ± 13.8⁎ - 102 ± 16.6 86 ± 14.4⁎ -
Body weight (kg) 84.3 ± 16.4 84.5 ± 16.2 85.0 ± 17.3 85.8 ± 11.8 85.0 ± 11.3 86.0 ± 12.4
Quality of life
Emotional domain 5.7 ± 0.7 6.2 ± 0.5⁎ 6.1 ± 0.6 5.5 ± 1.1 6.0 ± 0.7⁎ 5.9 ± 0.7
Physical domain 5.3 ± 0.7 6.2 ± 0.4⁎ 6.2 ± 0.7 5.4 ± 1.0 6.0 ± 0.6⁎ 6.1 ± 0.6
Social domain 5.6 ± 0.6 6.5 ± 0.4⁎ 6.5 ± 0.6 5.4 ± 1.3 6.3 ± 0.7⁎ 6.3 ± 0.6
Blood markers
HDL (mmol/L) 1.31 ± 0.3 1.42 ± 0.4 1.37 ± 0.3 1.29 ± 0.3 1.31 ± 0.3 1.37 ± 0.3
LDL (mmol/L) 2.54 ± 1.0 2.08 ± 1.1 2.43 ± 0.8 2.53 ± 1.1 2.52 ± 1.3 2.54 ± 0.9
Triglycerides (mmol/L) 1.46 ± 0.6 1.37 ± 0.7 1.27 ± 0.4 1.61 ± 0.7 1.56 ± 0.6 1.41 ± 0.6
Ferritin (μg/L) 140 ± 100 100 ± 75⁎ 88 ± 58 138 ± 89 99 ± 73⁎ 104 ± 66
Adiponectin (μg/mL) 5.77 ± 1.9 5.62 ± 1.6 6.39 ± 1.96‡ 5.12 ± 1.93 4.83 ± 1.84 5.64 ± 2.26¶
Glucose (mmol/L) 6.0 ± 1.1 5.8 ± 0.9 5.5 ± 0.6 6.6 ± 2.3 6.2 ± 1.2 6.2 ± 1.4
Hemoglobin (g/dL) 13.5 ± 1.0 13.7 ± 1.0 14.3 ± 1.0¶ 13.7 ± 1.2 13.9 ± 1.1§ 14.2 ± 1.8
Patients who changed their β-blocker dose during the study were excluded from analyses on heart rate. Patients in the analyses were n = 23 to 28 in AIT and n = 23 to 31 MCT. Resting
heart rate and work economy were not measured at 6m. Footnotes indicate significant changes. Values are mean ± SD. RER, Respiratory exchange ratio; HDL, high-density
lipoprotein; LDL, low-density lipoprotein.
⁎ From BL to 4w (P < .001) within groups.
† From 4w to 6m (P < .05) between groups.
‡ From 4w to 6m (P < .05) within groups.
§ From BL to 4w (P < .05) within groups.
║ From BL to 4w (P < .01) within groups.
¶ From 4w to 6m (P < .01) within groups.
Figure 2
VO2peak in AIT andMCT at baseline, 4w, and 6m. The bars represent ±
SEM. *P < .05, group comparison.
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that in men, and VO2peak decreased by 0.2 mLd kg
−1dmin−1
per year of age.
Maximum HR was 143 (SD 17) and did not differ
significantly between groups or time of testing. Both
groups showed significant improvements in HR recovery
between baseline and 4w, with no significant changes
between 4w and 6m (Table II).
At baseline, 31 of 38 patients (AIT 13, MCT 14) were
classified with reduced diastolic function (impaired 10,
pseudonormal 14, and restrictive: 7). The average left
ventricular volumes were normal, and EF slightly
reduced. No changes were seen in EF, end-diastolic
volume, or in any of the mitral annular velocity variables.
Early diastolic filling velocity (E) decreased after exercise
in the AIT group only (P = 0.023) (Table III).
Serum adiponectin, ferritin and hemoglobin changed
significantly over time (Table II). All 3 domains of
MacNew improved significantly between baseline and
4w, and remained so at 6m, with no significant difference
between the groups (Table II).
Exercise at home. Most of the subjects were doing
exercise training between 4w and 6m; the AIT subjects
did more interval training with high intensity (Table IV).
Discussion
Our main finding was that both AIT and MCT training
groups showed a significant increase in VO2peak, HR
recovery, and quality of life after a 4-week intense
rehabilitation program (at 4w). At follow-up 6 months
from discharge (6m), the AIT group showed a further
increase in VO2peak, whereas MCT did not.
Based on previous studies,4-6,14 we had hypothesized
that AIT would increase VO2peak more than MCT. After 4
weeks of exercise training, there was slight evidence for a
greater increase in VO2peak in the AIT group (group × 4w
interaction, P = .19). One reasonable explanation for the
lack of difference could be the relatively short duration of
the training period. The participation in additional
training sessions with various intensities at the rehabili-
tation center may also have reduced the difference
between the effects of the 2 training groups.
Low HR recovery is an independent predictor of
mortality in patients with cardiovascular disease.15 In our
study, AIT and MCT gave similar, significant increases in
HR recovery at 4w. Similar effects of exercise training
havepreviouslybeen reported,16whereasothers17 founda
higher HR recovery only after 2minutes.We are not aware
of any previous studies comparing the effect of different
exercise intensities on HR recovery in CABG patients.
Follow-up after 6 months
The AIT group increased their VO2peak significantly by
home exercise, whereas the MCT group maintained their
capacity. We speculate that the greater improvement in
the AIT group at 6m is due to more intense exercise
training at home, as outlined in Table IV. Others have
found reduced exercise capacity after home exercise,18
but patients attending a similar 4-week rehabilitation
program as in ours maintained aerobic capacity at 2 years
of follow-up.19 It might be that such intense programs
provide an educational setting and also a “kick-start” for
changing the activity patterns for these patients, beyond
what is obtained through outpatient rehabilitation.
In a prospective study of men and women with
coronary heart disease, Keteyian et al3 found an
approximate 15% reduced risk of death with every 1
mLd kg−1dmin−1 increase in VO2peak; hence, the differ-
ence seen in our study between AIT and MCT at 6m could
be important regarding mortality.
Echocardiography
After 4 weeks of exercise, we found no major changes
within or between groups for the systolic function of the
left ventricle. Because of the wide range of diastolic (dys)
function in the study population, we consider e′ a more
robust marker of the left ventricular diastolic function
than E, which has a nonlinear relation to diastolic
dysfunction because of its load dependency. Hence, the
change in E must be interpreted with caution. The fact
that none of the other variables characterizing diastolic
function changed after exercise supports the conclusion
that diastolic function was also unaffected by exercise.
There are 2 possible explanations for these results. First,
the training period might have been too short for
Table III. Echocardiography variables at baseline (BL) and 4w
AIT MCT
BL
(n = 19)
4w
(n = 19)
BL
(n = 19)
4w
(n = 19)
Systolic function
S′ (cm/s) 7.4 ± 1.4 6.8 ± 1.3 6.9 ± 1.0 6.9 ± 0.9
MAE (mm) 11.5 ± 2.1 11.1 ± 2.3 11.4 ± 1.8 11.7 ± 2.0
Diastolic function
E (cm/s) 67.7 ± 16 60.2 ± 16⁎ 65.8 ± 15 66.7 ± 15
A (cm/s) 56.2 ± 8 55.6 ± 11 57.1 ± 13 58.5 ± 13
e′ (cm/s) 9.4 ± 1.4 9.2 ± 2.0 9.1 ± 0.8 9.1 ± 1.2
a′ (cm/s) 10.6 ± 1.7 10.5 ± 1.4 9.4 ± 1.6 9.5 ± 1.7
E/e′ 7.3 ± 2.0 6.7 ± 2.0 7.4 ± 1.7 7.6 ± 2.0
E/A 1.2 ± 0.4 1.1 ± 0.4 1.2 ± 0.3 1.2 ± 0.5
DT (ms) 171 ± 38 173 ± 49 182 ± 49 182 ± 50
Volumes
EF % 48 ± 10 48 ± 9 44 ± 8 46 ± 9
EDV (mL) 103 ± 29 103 ± 32 118 ± 28 111 ± 30
ESV (mL) 54 ± 20 52 ± 18 66 ± 22 61 ± 23
Values are mean ± SD. S′, systolic mitral annular velocity; MAE, mitral annular
excursion; E, peak early diastolic mitral flow velocity; A, late diastolic mitral flow
velocity; e’, early diastolic mitral velocity; a’, late diastolic mitral velocity; DT,
deceleration time of the early diastolic mitral velocity; EF, ejection fraction; EDV, end
diastolic volume; ESV, end systolic volume.
⁎Different from MCT (P = .023).
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detectable adaptations to occur,6,20 and the increase in
VO2peak was thus due to peripheral adaptations. Second,
the patients were examined at rest, whereas changes
could have been present during activity. There are few
similar studies in CABG patients, but previous results in
patients with coronary heart disease are in agreement
with ours regarding systolic function.21 Regarding
diastolic function, previous studies have found some
signs of improvement in both mitral filling and tissue
Doppler–derived variables.21,22 In patients with overt
heart failure, however, AIT improves both systolic and
diastolic functions significantly.6
Blood markers
Serum adiponectin has been reported to increase after
moderate-to-high intensity exercise training in subjects
with the metabolic syndrome,5 type 2 diabetes melli-
tus,23,24 and obesity,25 although the data are not
consistent.26 To our knowledge, this study is the first to
investigate adiponectin in patients with coronary artery
disease undergoing an exercise program. The insignifi-
cant changes in adiponectin at 4w may be due to the
short training period. Also, it can be caused by the need
for a supercompensation period after a training program
to reveal the real adaptation. In line with these
assumptions, we observed that both groups had in-
creased levels of adiponectin at 6m. Two uncontrolled
trials on similar short training periods have found
different results.23,24 Blüher et al23 found significant
increases in subjects with both normal and impaired
glucose tolerance, as well as in subjects with type 2
diabetes mellitus after 4 weeks of exercise training. In
contrast, Oberbach et al24 found only significant increase
in subjects with impaired glucose tolerance or type 2
diabetes mellitus and not in subjects with normal glucose
tolerance.24 Eriksson et al27 however found a large
increase in adiponectin in healthy men after a 14-day
long skiing expedition.
Ferritin decreased significantly in both groups at 4w.
In advance, we had no specific hypothesis about
changes in ferritin throughout the study, but some
studies have linked increased ferritin levels to increased
incidence of coronary artery disease (for a review, see,
eg, reference 28).
Quality of life
Besides improved physical capacity, the ultimate goal is
to improve quality of life for these patients. Quality of life
increased significantly in both groups at 4w and remained
improved at 6m. Dixon et al29 maintain that a change of
0.5 in MacNew score is clinically important and
equivalent to the improvement seen after revasculariza-
tion. We saw changes larger than this in all 3 domains
from baseline to 4w and therefore argue that both groups
had significantly better quality of life after the rehabilita-
tion period. Even more important, this improvement was
maintained at the follow-up test.
Conclusions
VO2peak and HR recovery increased significantly after a
brief but intense exercise program of both moderate
continuous exercise training (MCT) and AIT in coronary
artery bypass patients. Aerobic interval training was
superior to MCT in increasing VO2peak and HR recovery 6
months after ending the formal program. Quality of life
increased significantly after 4 weeks of rehabilitation and
remained improved for 6 months in both training groups.
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